|
Delayed
TEL AVIV STOCK EXCHANGE
16:31:13 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1,458.00 ILa | -2.93% |
|
-7.25% | -9.89% |
| 09-08 | InterCure Regains Nasdaq Compliance | MT |
| 08-25 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
Chart: Technical Analysis
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| INCR | Delayed | |
Nasdaq
| INCR | Delayed | |
|
CBOE
| INCR | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1,609 | 1,795 | 2,350 |
| Spread/Res. | -9.14% | -18.55% | -37.79% |
| Spread/Supp. | -1.95% | +28.25% | +26.96% |
| Support | 1,491 | 1,140 | 1,151.5 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- INCR Stock
- Charts InterCure Ltd.
Select your edition
All financial news and data tailored to specific country editions
